SCHEMBL10098366

SCHEMBL10098366

CC1=CCC(c2nn(C)c3ncnc(N)c23)C=C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 4/20 0.73
PIK3CD O00329 12/20 0.41
PIK3CA P42336 11/20 0.41
PIK3CB P42338 11/20 0.41
PIK3CG P48736 11/20 0.41
PRKDC P78527 11/20 0.41
ABL1 P00519 9/20 0.41
EGFR P00533 8/20 0.41
HCK P08631 8/20 0.41
SRC P12931 8/20 0.41
MTOR P42345 8/20 0.41
EPHB4 P54760 8/20 0.41
KDR P35968 8/20 0.41
PI4KB Q9UBF8 2/20 0.41
NUDT14 O95848 1/20 0.36
NUDT5 Q9UKK9 1/20 0.36
LRRK2 Q5S007 3/20 0.36
DYRK1A Q13627 2/20 0.33
DAPK3 O43293 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19763994 0.84 RET (1.00) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL726543 0.81 RET (0.80) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL726969 0.79 RET (0.77) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL726637 0.78 RET (0.76) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL726987 0.76 RET (0.71) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL728046 0.75 RET (0.69) RETPIK3CDABL1EGFRSRC
SCHEMBL728202 0.75 RET (0.69) RETPIK3CDABL1EGFRSRC
SCHEMBL726560 0.75 RET (0.69) RETABL1EGFRSRCMTOR
SCHEMBL10098362 0.74 RET (0.56) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL726350 0.73 RET (0.66) RETABL1EGFRHCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003544-A1 PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2012-01-12 WO disclosed